Cuprina (Cayman) Limited (CUPR)
NasdaqCM: CUPR
· Precio en tiempo real · USD
2.97
+0.05 (1.71%)
Al cierre: Aug 18, 2026, 3:57 PM
Cuprina (Cayman) Limited (CUPR) Stock Price, Analysis & Data
1.71% (1D)
| Precio de compra | n/a |
| Capitalización de mercado | 7.96M |
| Ingresos (TTM) | 49.89K |
| Beneficio neto (TTM) | -4.67M |
| Beta | n/a |
| EPS (TTM) | -1.43 |
| Ratio PER (TTM) | n/a |
| Adelante PE | n/a |
| P/B (TTM) | 2.00 |
| P/S (TTM) | 159.60 |
| Earnings Date | n/a |
| Precio de venta | n/a |
| Volumen | 293 |
| Volumen medio (20D) | 3,138,943 |
| Abierto | 2.82 |
| Anterior Cerrar | 2.92 |
| Rango del día | 2.72 - 3.02 |
| Rango de 52 semanas | 1.76 - 19.60 |
| analista | n/a |
| Precio objetivo | n/a |
| Dividendos | n/a |
| Fecha ex dividendo | n/a |
Acerca de CUPR
Cuprina Holdings (Cayman) Limited, a biomedical and biotechnology company, focuses on the development and commercialization of products for the management of chronic wounds. The company manufactures and distributes a line of medical grade sterile blowfly larvae bio-dressing products used as a biological debridement tool for chronic wounds under the MEDIFLY brand name. It is also developing collagen dressings, including sponges, particles, and hyd...
Industria Medical Instruments & Supplies
Sector Healthcare
IPO Fecha Apr 10, 2025
Empleados 10
Bolsa de Valores NasdaqCM
Símbolo bursátil CUPR
Sitio web https://www.cuprina.com.sg
Desempeño financiero
En 2025, los ingresos de Cuprina (Cayman) fueron 49.89K, un aumento de 3.26% en comparación con 48.32K del año anterior. Las ganancias fueron -4.67M, un aumento de 199.48%.
Estados financieros